跳至主要内容
临床试验/DRKS00022845
DRKS00022845招募中不适用

eurological rehabilitation outcome of the treatment of patients with COVID-19 disease - NRO-COV-50

eurologische Klinik/ Station I2, Klinikum der Universität München0 个研究点目标入组 500 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Age> = 18 years
  • COVID-19 pathogen detection using PCR (not for control group)
  • COVID-associated rehabilitation diagnosis (e.g. CIP / CIM, stroke, GBS, encephalopathy) For the non-COVID-19 CIP / CIM control group: Proven CIP / CIM as a qualifying NNFR diagnosis
  • Treatment from 1.1.2017 (i.b. for retrospective CIP / CIM control group)
  • Treatment in the NNFR for at least 48 hours
  • For a prospective sub-project: Written consent to study participation after detailed information

排除标准

  • For the prospective sub-project: Refusal to participate in the study
  • Pregnant or breastfeeding

研究者

发起方
eurologische Klinik/ Station I2, Klinikum der Universität München

相似试验